Genome sequencing refers to the process of determining the sequence of a cell’s genetic code.
Over the last decade, advances in next generation sequencing technologies has enabled significant progress in our understanding of the biology of cancer cells. By comparing the differences between the genetic sequence of cancerous and normal cells, we can better understand the biological pathways associated with cancer onset and progression and this information can be used to further improve, or develop new treatment strategies. NCARD currently has a number of projects that involve genomic sequencing and analyses; which are listed below.